Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of natural rubber foams: Effect of foaming agent content and processing conditions on the cellular structure and mechanical properties.

Cellular polymers·2026
Same author

Morphological, thermal and mechanical properties of polypropylene foams via rotational molding.

Cellular polymers·2026
Same author

Thermally conductive and electrically insulative polypropylene composites based on polymethylsilsesquioxane microparticles.

Journal of thermoplastic composite materials·2026
Same author

Self-Sensing NiFe@N-doped Carbon Aerogel: Integrating Excellent Radar Stealth, Inherent Structural Health Monitoring, Thermal Management, and Flame Retardancy.

Nano-micro letters·2026
Same author

Search and prove of efficient inhibitors against papain-like protease from SARS-CoV-2.

Journal of virological methods·2025
Same author

Wood fiber reinforced oxidized starch-based composite foam: biobased, flame retardant and hydrophobic.

Carbohydrate polymers·2025

Related Experiment Video

Updated: Jun 6, 2026

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

10.2K

A review on hemostatic materials: Past, present and future developments.

Xiao Yuan Chen1, Anguo Xiao2, Yang Wang2

  • 1Hunan Provincial Key Laboratory of Water Treatment and Functional Materials, College of Chemistry and Materials Engineering, Hunan University of Arts and Science, Changde, China; Department of Chemical Engineering, Université Laval, Quebec City, Canada; Department of Molecular Medicine, CHU Research Center and Laval University, Canada.

Biomaterials Advances
|April 2, 2026
PubMed
Summary

Developing advanced hemostatic materials is crucial for controlling bleeding and improving wound healing. This review explores various hemostatic agents, their forms, and market status, addressing key challenges and innovations.

Keywords:
Antibacterial activityBiodegradabilityBlood lossClotting timeHemostatic materials

More Related Videos

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

736
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.8K

Related Experiment Videos

Last Updated: Jun 6, 2026

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

10.2K
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

736
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.8K

Area of Science:

  • Biomaterials Science
  • Surgical Innovation
  • Wound Management

Background:

  • Hemostatic materials are vital for controlling bleeding in diverse medical settings, yet current options have limitations.
  • The development of safe, effective, and user-friendly hemostatic agents is a significant clinical need.
  • Numerous hemostatic agents, including inorganic, biobased, peptide, protein, synthetic polymers, and hybrid systems, have been developed.

Purpose of the Study:

  • To comprehensively review hemostatic materials, covering their classifications, mechanisms, and market landscape.
  • To analyze recent advancements, research developments, and commercial products in hemostasis.
  • To discuss key challenges and future trends in the field of hemostatic materials.

Main Methods:

  • Material classification based on composition (inorganic, biobased, synthetic, hybrid).
  • Morphological classification including nanofibers, gels, sponges, dressings, powders, and injectable solutions.
  • Review of mechanisms of action, characterization techniques, and market status.

Main Results:

  • Hemostatic materials are engineered into various functional forms to meet specific clinical needs.
  • Performance metrics like clotting time and blood loss, alongside properties such as biocompatibility and biodegradability, are critical evaluation factors.
  • The review synthesizes information on commercial products and ongoing research developments.

Conclusions:

  • Continued innovation in hemostatic materials is essential to overcome existing limitations and enhance patient outcomes.
  • Understanding material properties, performance metrics, and market trends is key to advancing hemostatic technology.
  • Future research should focus on developing materials with improved efficacy, safety, and user-friendliness.